C3 glomerulopathy: consensus report. - Wikidata - awgldk - TriplyDB

C3 glomerulopathy: consensus report.

C3 glomerulopathy: consensus report.

http://www.wikidata.org/entity/Q37348685

about

Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN Overview of C3 Glomerulopathy The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy Complement cascade and kidney transplantation: The rediscovery of an ancient enemy Current Understanding of the Role of Complement in IgA Nephropathy Hemolytic uremic syndrome: toxins, vessels, and inflammation C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.Dynamics of complement activation in aHUS and how to monitor eculizumab therapy Podocyte dysfunction in atypical haemolytic uraemic syndrome.Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.Complement in disease: a defence system turning offensive Anti-complement-factor H-associated glomerulopathies.C3 glomerulonephritis in multiple myeloma: A case report and literature review Different types of glomerulonephritis associated with the dysregulation of the complement alternative pathway in 2 brothers: A case report.Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.Defining the complement biomarker profile of C3 glomerulopathy Immunosuppressive Medications.Current concepts in C3 glomerulopathy.Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.Complement involvement in kidney diseases: From physiopathology to therapeutical targeting Pathogenesis of glomerular haematuria.Complement Activation in Patients with Focal Segmental Glomerulosclerosis.A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy Timing of eculizumab therapy for C3 glomerulonephritis.Characterization of C3 in C3 glomerulopathy.Eculizumab in Pediatric Dense Deposit Disease.Applying complement therapeutics to rare diseases.Small vessel microembolization and acute glomerulonephritis following infection of aesthetic filler implants New classification of membranoproliferative glomerulonephritis: a good start but a long way to go.Annexin A2 Enhances Complement Activation by Inhibiting Factor H Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy.Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.The Genetics of Ultra-Rare Renal Disease.Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor.Complement related kidney diseases: Recurrence after transplantation.Atypical Plasmacytic Proliferation in a Case of C3 Glomerulopathy: Pathophysiology Demystified A healthy female with C3 hypocomplementemia and C3 Nephritic Factor

P2860

Q26741542-6783BAF1-B7F0-46DA-A985-AA6D0CFD2C34 Q26747262-54E5EF0B-AB6D-431C-BF66-C1240AFEB1E9 Q26752555-39392908-6560-40E9-8FA3-D055F568481F Q26829790-AB52A466-BEEF-4046-B88F-EE2CF019175C Q26852163-EE8615EB-ADCB-4380-8D08-ED66A0D4CF2F Q28083347-A962DED3-8654-4B41-BAC6-1D0EE2CCF8F4 Q30274884-7BDC6427-43F9-4CC1-B459-6DD060CB495A Q33416519-F4F9C721-38F5-46E5-81B8-558638A87F9C Q33419853-E81FCB76-35BB-4385-9610-BF28EAA94A77 Q33425891-AA71FE94-B6EA-4603-86C4-369ADA82F86C Q33432423-4730CF20-86CA-40B8-AF27-DB61C6F4F999 Q33434103-0A13BB2F-2D23-4D6C-ADE3-2967CDA7C2B3 Q33595318-C008AF39-8B7B-4C65-A397-60A40E100B5F Q33818095-6FF49EC8-538B-4380-BA06-40C70E7F6F22 Q34427591-E280002B-9D7D-47B3-B862-B2B7867E21F7 Q34455125-A5621A9F-355F-46D4-893B-54889265F931 Q34484801-D58FC772-AE7F-4662-BDFE-0F3501F691BB Q34574482-F7332654-1ECE-4836-BA8E-7493C7702BC8 Q35246525-9921FB84-F129-4BE8-97F6-FFC51FED6C7F Q35567841-59CE7CE4-04B0-4F00-B1F9-8D13A94D1071 Q35567846-1FFB95F0-F9CC-4EF2-B0EF-146036BBBF90 Q35763276-E9660DA9-E93F-4BC7-9561-AD9AA603AFA2 Q35809292-6702E52B-6E2B-468B-B102-AD3545A58298 Q35877192-EECBCE39-3F9F-4968-963F-C626AEACF850 Q35891599-9706E89C-33B1-47B3-B7DA-685D8D2CC2A8 Q36099921-388C4099-C1EB-4190-B864-9385B3B47AF4 Q36123605-FB2C64EA-8023-4580-A922-0ED0F5E7D677 Q36315497-9115E037-E2D3-49BF-BA78-F62319265F8E Q36446410-DFA25ACF-3F56-4F24-9061-83908D5D781B Q36466296-9C993F39-C6FC-4AEC-9860-D4D994C32234 Q36495141-FDE7BDF7-456A-4B62-A6A2-5843A921F64E Q36907945-3B369C32-E307-429C-8416-001457AFB019 Q36951249-12BEBA78-545B-40D8-9971-80DBCB375EEA Q36965127-5663A342-FDEB-421F-9A63-A4B969153BBC Q37017177-BAD50C2A-8803-4AC3-8814-C0F994181A3E Q37032691-C68ADD71-2940-4BB0-9F6D-6457AF725DC4 Q37285007-F968AC1A-5127-45FE-9761-02D21683E277 Q37522557-BE403783-DFBE-4D6C-AA11-13A2D47D069C Q37632326-C83E9690-C926-4E48-B46E-6DFDA08AE427 Q37661697-FE427F10-D256-46A4-9780-0B1EA9F36B69

P2860

C3 glomerulopathy: consensus report.

http://www.wikidata.org/entity/Q37348685

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

C3 glomerulopathy: consensus report.

@en

C3 glomerulopathy: consensus report.

@nl

type

label

C3 glomerulopathy: consensus report.

@en

C3 glomerulopathy: consensus report.

@nl

prefLabel

C3 glomerulopathy: consensus report.

@en

C3 glomerulopathy: consensus report.

@nl

P1433

Q37348685-5E4744EE-CE46-4347-8B9F-F735F55A7C8B

P1476

Q37348685-F5FA3E98-C558-4103-AB2B-D6F0A6973E8C

P2093

Q37348685-0030977D-F59F-4745-9B63-C54329DDACE1

Q37348685-06142E3F-6B03-4900-A551-579EA5025A2B

Q37348685-0D622676-81D9-413C-AE7D-A1EEC9F4EB54

Q37348685-0F4BA764-E5D8-4728-B79B-AAFCD4DBBDED

Q37348685-0FBEEF6B-E77B-483B-9E51-FE996933B7F3

Q37348685-10737D02-5503-4DD6-BD42-7AF1689886C1

Q37348685-10AA8483-AB62-492B-8D46-BD6B066D7740

Q37348685-2B922EBE-8176-425B-9C17-0F7685FCEF43

Q37348685-35AC1C71-9B99-455B-AD81-6FBD9E0E58BF

Q37348685-3BB533D7-2F6E-4E6A-974D-DC996FB65DF7

P275

Q37348685-B3AF51E8-08EE-45C4-8F82-FCD4A86A1020

P2860

Q37348685-0148DC55-02AB-41BA-B746-264EAE7DDE31

Q37348685-03F2886C-890E-47B4-B3D5-CBCF8F282CD5

Q37348685-06C4FFAF-859B-42BB-B016-2D8273EBF432

Q37348685-09904B68-76D0-4210-BBFE-A0A66C5C7E1C

Q37348685-0EFE9089-CAE5-456E-B7FE-425D1E37B053

Q37348685-3C4A4E11-9ED6-46CE-A08A-12247E224866

Q37348685-3DB4373A-6D7E-4A0F-B606-6438BDE0A3C3

Q37348685-42C1C2F2-1315-4FDC-B28B-452452E09B58

Q37348685-478A5BAB-3626-41D8-A632-BF46E5BB4C13

Q37348685-529C911E-400C-4B74-81EE-413235867C0E

P2888

Q37348685-3380DC7B-431F-4025-A7D4-1BD025FA1A39

P304

Q37348685-21B8928A-60E4-4715-BB2A-9965F248FC4C

P31

Q37348685-4066FBD7-2128-444A-BF51-C77F91F7C73C

P356

Q37348685-77960CA2-22FB-4B4B-A832-702ECF23D816

P407

Q37348685-E956D873-8FDA-47E8-851A-12F1C3049DD9

P433

Q37348685-2DCCE89E-09B9-4A61-8C7E-453E15D43551

P478

Q37348685-8C1237A4-AACF-45F4-A0A6-ABAD1F5CCBBF

P50

Q37348685-329A60BB-AACE-48EC-8B5C-E1E2590798A9

Q37348685-412120F6-CC8E-4561-BD81-DF2C91CD9066

Q37348685-5A39BBDF-95B1-425B-9FCF-01486571EC9F

Q37348685-6C1F684C-3CB8-4080-AFE0-C2CF2352A14E

Q37348685-BD39D68C-0096-44D0-BAB3-8C36589DAA00

Q37348685-DCE5C87D-7F75-41C2-AEE9-59D8C25FA1DC

P577

Q37348685-019A7EED-B837-498A-80A1-93F8B86D9DB1

Q37348685-EE157E73-3093-40F6-ACD9-648BB0A076B3

P5875

Q37348685-528E4BB1-9564-44D7-8E1C-438F44AF5C82

P6179

Q37348685-A10D52AA-3952-480F-86AA-20F8EC3DD0F4

P698

Q37348685-98064F69-1432-465D-AB3E-6E261C647427

P921

Q37348685-F67612BB-323A-48B3-ACEF-2566DA43403A

P932

Q37348685-CC024DA9-8410-43CE-BA99-0279587CDFBD

P356

P1433

Kidney International

P1476

C3 glomerulopathy: consensus report.

@en

P2093

Agnes B Fogo

http://www.w3.org/2001/XMLSchema#string

B Paul Morgan

http://www.w3.org/2001/XMLSchema#string

Camille Bedrosian

http://www.w3.org/2001/XMLSchema#string

Carla M Nester

http://www.w3.org/2001/XMLSchema#string

Charles E Alpers

http://www.w3.org/2001/XMLSchema#string

Claire L Harris

http://www.w3.org/2001/XMLSchema#string

Cynthia C Nast

http://www.w3.org/2001/XMLSchema#string

D Keith Peters

http://www.w3.org/2001/XMLSchema#string

Elena Goicoechea de Jorge

http://www.w3.org/2001/XMLSchema#string

Fadi Fakhouri

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

Eculizumab for dense deposit disease and C3 glomerulonephritis

Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H

Eculizumab in a patient with dense-deposit disease

Dense deposit disease is not a membranoproliferative glomerulonephritis

Eculizumab for the Treatment of Dense-Deposit Disease

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice

P2888

P304

1079-1089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2013.377

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Véronique Frémeaux-Bacchi

Santiago Rodriguez de Córdoba

Matthew C Pickering

Richard J Smith

P577

2013-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258202846

http://www.w3.org/2001/XMLSchema#string

P6179

1005163409

http://www.w3.org/2001/XMLSchema#string

P698

24172683

http://www.w3.org/2001/XMLSchema#string

P921

glomerulonephritis

P932

3842953

http://www.w3.org/2001/XMLSchema#string